High hydrostatic pressure treatment generates inactivated mammalian tumor cells with immunogeneic features

High Hydrostatic Pressure for Development of Vaccines

(2016) ADRIENNE E. H. SHEARER et al.   JOURNAL OF FOOD PROTECTION

Immunogenic cell death modalities and their impact on cancer treatment

(2009) Oliver Kepp et al.   APOPTOSIS

Radiochemotherapy for Bladder Cancer

(2009) O.J. Ott et al.   CLINICAL ONCOLOGY

Novel strategies for improved cancer vaccines

(2009) Xiaochuan Chen et al.   Expert Review of Vaccines

New perspectives in cancer immunotherapy and immunomonitoring

(2009) Viktor Umansky et al.   Future Oncology

AnnexinA5 renders dead tumor cells immunogenic—implications for multimodal cancer therapies

(2009) Benjamin Frey et al.   Journal of Immunotoxicology

Biotechnology under high pressure: applications and implications

(2009) Abram Aertsen et al.   TRENDS IN BIOTECHNOLOGY

Cellular immunotherapy for multiple myeloma

(2008) Jacalyn Rosenblatt et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines

(2008) Tanja D. de Gruijl et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Molecular Interactions between Dying Tumor Cells and the Innate Immune System Determine the Efficacy of Conventional Anticancer Therapies

(2008) L. Apetoh et al.   CANCER RESEARCH

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009

(2008) G Kroemer et al.   CELL DEATH AND DIFFERENTIATION

Cells Under Pressure – Treatment of Eukaryotic Cells with High Hydrostatic Pressure, from Physiologic Aspects to Pressure Induced Cell Death

(2008) Benjamin Frey et al.   CURRENT MEDICINAL CHEMISTRY

Immunogenic cancer cell death: a key-lock paradigm

(2008) Antoine Tesniere et al.   CURRENT OPINION IN IMMUNOLOGY

Is interleukin-1 a good or bad ‘guy’ in tumor immunobiology and immunotherapy?

(2008) Ron N. Apte et al.   IMMUNOLOGICAL REVIEWS